Skip to main content
Delfa

← Trials/Trial dossier/NCT00488670

TerminatedPhase 3

Escitalopram and Depression in Elderly Alzheimer's Patients

An Open-label Study of Escitalopram in the Treatment of Major Depressive Disorder in Elderly Patients With Alzheimer's Disease

Asset

Escitalopram

Listed sites

2

Recruiting sites

-

Enrollment

50

estimated

Study population

Alzheimer’s disease

Key I/E criterion

•Alzheimer's disease

Primary endpoint

•Cornell Scale for Depression in Dementia (CSDD) from baseline

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

Org study IDH07-00050
NCT IDNCT00488670

Timeline

Milestones

Study first posted2007-06-20estimated
Study start2010-12 (month precision)
Primary completion2011-06actual (month precision)
Study completion2011-06actual (month precision)
Last update posted2011-06-06estimated

Assets

Drug assets

Escitalopram

Study populations

Who this study enrolls

Alzheimer’s disease

Eligibility

Who can enroll

Minimum age50 Years
SexAll
Healthy volunteersNot accepted

Eligibility criteria

•> 50 years
•Male \& female
•Alzheimer's disease
•Depressive episode

Endpoints (2)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Behavior / neuropsychiatric

2 endpoints
Primary/protocol endpoint

Change in Cornell Scale for Depression in Dementia (CSDD) from baseline.

change from baseline, improvement

Secondary/protocol endpoint

Montgomery-Åsberg Depression Rating Scale; Neuropsychiatric Inventory; Alzheimer's Disease Cooperative Study

Neuropsychiatric Inventory (NPI)

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 21, 2026
Endpoint classificationDelfa ADRD endpoint taxonomy
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 21, 2026 snapshot.